| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 79.19M | 168.83M | 563.54M | 441.91M | 608.16M |
| Gross Profit | 8.26M | 100.63M | 402.39M | 349.54M | 190.49M |
| EBITDA | -22.82M | -118.18M | -108.70M | -57.80M | -723.55M |
| Net Income | -2.10M | -283.75M | -59.90M | -85.33M | -238.68M |
Balance Sheet | |||||
| Total Assets | 118.76M | 549.21M | 1.63B | 1.67B | 1.79B |
| Cash, Cash Equivalents and Short-Term Investments | 74.76M | 43.35M | 144.25M | 246.36M | 255.68M |
| Total Debt | 80.08M | 149.20M | 68.85M | 640.25M | 752.95M |
| Total Liabilities | 167.27M | 585.44M | 1.17B | 1.16B | 1.23B |
| Stockholders Equity | -73.89M | -54.34M | 229.72M | 202.99M | 211.99M |
Cash Flow | |||||
| Free Cash Flow | -43.41M | -161.13M | 72.20M | -70.19M | -206.10M |
| Operating Cash Flow | -43.41M | -159.90M | 94.28M | -50.75M | -154.00M |
| Investing Cash Flow | 33.05M | 14.10M | -173.27M | -12.79M | -23.33M |
| Financing Cash Flow | -3.74M | 62.37M | -8.81M | -10.73M | 18.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.98B | 9.77 | 12.50% | 8.99% | 1.54% | -16.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
45 Neutral | HK$245.00M | -3.13 | -12.85% | ― | -24.98% | 3.97% | |
44 Neutral | HK$124.31M | -1.24 | -2.05% | ― | -34.40% | -3490.18% | |
43 Neutral | HK$47.95M | -10.66 | 61.00% | ― | -53.10% | 87.31% | |
40 Underperform | HK$218.92M | -2.79 | -8.30% | ― | -22.60% | 28.57% |